Logo image
Sign in
A phases II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
Journal article   Peer reviewed

A phases II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study

John K. Chan, Wei Deng, Robert Higgins, Albert J. Bonebrake, Michael Hicks, Krishnansu Sujata Tewari, Stephanie Gaillard, Pedro T Ramirez and Bradley J. Monk
Journal of clinical oncology, Vol.33(15_suppl), pp.e16599-e16599
05/20/2015

Abstract

Abstract only

Metrics

6 Record Views

Details